MindMed is a neuro-pharmaceutical company focused on discovering and developing medicines based on psychedelics. The company works on addressing the opioid crisis and other forms of addiction by developing versions of psychedelic substances such as LSD, psilocybin and ibogaine without hallucinogenic effects while maintaining their medicinal properties.
|Employees (est.) (Feb 2020)||11|
MindMed total Funding
MindMed latest funding size
Time since last funding
|5 months ago|
|Kevin O'Leary, Bruce Linton, James Bailey|
When was MindMed founded?
MindMed was founded in 2019.
Who are MindMed key executives?
MindMed's key executives are Stephen L. Hurst, JR Rahn and Donald Gehlert.
How many employees does MindMed have?
MindMed has 11 employees.
Who are MindMed competitors?
Competitors of MindMed include Alfasigma, Emergo Therapeutics and Mitotech.
Where are MindMed offices?
MindMed has an office in Toronto.
How many offices does MindMed have?
MindMed has 1 office.
Receive alerts for 300+ data fields across thousands of companies